Published Guidance, NICE advice and quality standards

Showing 11 to 15 of 15

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Cetuximab, bevacizumab and panitumumab for the treatment of metastatic colorectal cancer after first-line chemotherapy: Cetuximab (monotherapy or combination chemotherapy), bevacizumab (in combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy	TA242	25 January 2012	25 January 2012
Bevacizumab and cetuximab for the treatment of metastatic colorectal cancer	TA118	24 January 2007	1 January 2012
Bevacizumab in combination with oxaliplatin and either fluorouracil plus folinic acid or capecitabine for the treatment of metastatic colorectal cancer	TA212	15 December 2010	15 December 2010
Laparoscopic surgery for colorectal cancer	TA105	23 August 2006	23 August 2006
Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer	TA61	27 May 2003	27 May 2003